Momenta Pharmaceuticals, Inc. (MNTA)

[RockRat]

"I don't believe MNTA's IVIG product was part of the Baxter deal." Never said it was. How uninformed do you think I am?

I am saying that some sialylation methods that appear applicable to the MNTA IVig program are disclosed in patents that appear to be chiefly concerned with the biosimilar program. I am suggesting that because of that, Baxter has probably already had a closer look than most potential suitors and has passed. I am suggesting they are more interested in a directly competing technology. I am saying that I may not be right about all this, but it would be a good idea for us to look at competing efforts and think about the IP and timing of certain related events.

Am I making myself clear?

Regards, RockRat

Aside to DFRAI re CNAT: seen the name, done no DD, and have no opinion.